Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

1.17
Delayed Data
As of 3:59pm ET
 -0.01 / -0.85%
Today’s Change
0.80
Today|||52-Week Range
3.53
-21.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues457.0K1.5M705.0K1.9M
 
 
 
 
 
Cost of Goods Sold2.4M3.1M3.9M3.4M
 
 
 
 
 
Depreciation And Amortization846.0K877.0K879.0K723.0K
 
 
 
 
 
 
Operating ExpensesGross Income-2.8M-2.5M-4.1M-2.3M
 
 
 
 
 
General Expenses7.2M4.8M7.6M7.2M
 
 
 
 
 
Research And Development3.4M3.2M3.8M3.8M
 
 
 
 
 
Total Operating Expenses10.5M8.7M12.3M11.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.0M-7.3M-11.6M-9.4M
 
 
 
 
 
Extraordinary Credit0.002.8M14.8M0.00
 
 
 
Extraordinary Charge-1.1M---1.4M-801.0K
 
 
 
 
Interest Expense On Debt2.2M2.2M2.2M2.2M
 
 
 
 
 
Other Expenses0.00-9.0K-5.0K-10.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.3M-6.7M-404.0K-12.5M
 
 
 
 
 
Net Income-13.3M-6.7M-404.0K-12.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.4M19.4M19.8M19.8M
 
 
 
 
 
Shares To Calculate EPS Diluted17.4M19.4M19.8M19.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.77-$0.35-$0.02-$0.63
 
 
 
 
 
EPS Diluted-$0.77-$0.35-$0.02-$0.63